Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
VI ›
VIVOLYTE
Trademark search for:
VIVOLYTE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2016-03-18 — Application filed
2016-03-22 — Application filed
2016-03-23 — Application filed
2016-06-28 — Assigned to examiner
2016-06-29 — Assigned to examiner
2016-07-12 — Final disposition recorded
2016-07-12 — Final disposition recorded
2016-07-12 — Final disposition recorded
2017-01-11 — Office action issued
2017-01-31 — Assigned to lie
2017-02-08 — Correspondence received in law office
2017-02-08 — Teas/email correspondence entered
2017-02-22 — Data modification completed
2017-02-22 — Approved for pub - principal register
2017-03-03 — Law office publication review completed
2017-03-22 — Notification of notice of publication e-mailed
2017-04-11 — Published for opposition
2017-04-11 — Official gazette publication confirmation e-mailed
2017-06-06 — Noa e-mailed - sou required from applicant
2017-06-19 — Teas change of correspondence received
2017-10-26 — Teas revoke/app/change addr of atty/dom rep received
2017-10-26 — Attorney/dom.rep.revoked and/or appointed
2018-01-08 — Application abandoned
2018-01-08 — Application abandoned
2018-01-08 — Final status recorded
Owner Information
VIVOLINE MEDICAL AB
S-22478 LUND SE
VIVOLINE MEDICAL AB
S-22478 LUND SE
Correspondent
Michael J. Hynak Hynak & Associates, PC 812 South Courthoue Rd. Arlington, VA 22204 UNITED STATES
Filing Details
Filing Date:
2016-03-18
Status Date:
2018-01-08
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.